鷺燕醫藥(002788.SZ):子公司取得一項發明專利證書
格隆匯 11 月 30日丨鷺燕醫藥(002788.SZ)公佈,公司控股子公司智慧康源(廈門)科技有限公司於近日收到國家知識產權局頒發的《發明專利證書》,涉基於自適應閾值小波變換的心電信號降噪方法。
近年來,公司大力推進橫向擴張和縱向發展,積極導入以信息化、智能化為引領的“三維立體”發展戰略,不斷推進健康醫療領域人工智能、大數據的研發。上述發明專利的取得體現了公司的研發及創新能力,有利於公司進一步完善知識產權保護體系,充分發揮自主知識產權優勢,促進技術創新,提升公司核心競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.